Literature DB >> 124235

Hypertensive pulmonary vascular disease associated with patent ductus arteriosus. Primary or secondary?

F B Bessinger, L C Blieden, J E Edwards.   

Abstract

In an infant with patent ductus arteriosus and pulmonary hypertension, elevated pulmonary vascular resistance persisted following ligation of the ductus. Histologic examination of a pulmonary biopsy at two years of age and tissue obtained at autopsy at three years of age showed obstructive pulmonary vascular disease. The question as to whether the organic vascular lesions are secondary to the effects of the patent ductus or part of pulmonary hypertension cannot be resolved. The age of the patient favors a primary etiology.

Entities:  

Mesh:

Year:  1975        PMID: 124235     DOI: 10.1161/01.cir.52.1.157

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Aortic dissection with extension to a patent ductus arteriosus.

Authors:  Emir Festic; Robert M Steiner; Eileen Spatz
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

Review 2.  Congenital heart disease: the ductus arteriosus as pathfinder.

Authors:  R M Marquis
Journal:  Br Heart J       Date:  1987-11

3.  Small ventricular septal defect associated with severe pulmonary hypertension.

Authors:  L C Blieden; J H Moller
Journal:  Br Heart J       Date:  1984-07

Review 4.  [Anesthesia in children and adolescents with congenital heart defects].

Authors:  T Baehner; O Boehm; M Kliemann; I Heinze; J Breuer; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2015-06       Impact factor: 1.041

5.  Echocardiographic Prediction of Left Ventricular Dysfunction After Transcatheter Patent Ductus Arteriosus Closure in Children.

Authors:  Miao Hou; Weiguo Qian; Bo Wang; Wanping Zhou; Jianmin Zhang; Yueyue Ding; Qiuqin Xu; Jie Huang; Jie Shen; Lei Cao; Haitao Lv; Ling Sun
Journal:  Front Pediatr       Date:  2019-10-15       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.